ApoPharma: Drug Study Recruitment Collateral

Drug study recruitment collateral designed for ApoPharma’s FIRST (Ferriprox® Iron Overload Sickle Cell Trial) drug study. FIRST is a 52-week study may lead to improved outcomes of sickle cell disease.

Study materials include:
• Squarespace website
• Postcard
• Social media graphics

Tags
Pharmaceutical